Clinical Trial Update: Evaluate the Efficacy, Safety, and Pharmacokinetic Profile and Immunogenicity of Subcutaneous Netakimab in Chinese Adult Patients With Active Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating subcutaneous netakimab in Chinese adults with active ankylosing spondylitis has completed its evaluation of efficacy, safety, pharmacok…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Netakimab (netakimab)

Snippet

Sponsor: SPH-BIOCAD (HK) Limited | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED